(SCI)
Treatment with low-dose sorafenib in combination with a novel benzimidazole derivative bearing a pyrolidine side chain provides synergistic anti-proliferative effects against human liver cancer
RSC Advances
M-H Hsu, S-M Hsu, Y-C Kuo, C-Y Liu, C-Y Hsieh, Y-C Twu, C-K Wang, Y-H Wang and Y-J Liao
2020-10-28